Pierluigi Castellone

Brain Products GmbH

Affiliated withBrain Products GmbH Brain Products GmbH

Research Area

Biography

Pierluigi Castellone has not added Biography.
If you are Pierluigi Castellone and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 48	2013

Other Publications

Article	Year
Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases. Digestive diseases and sciences\| PubMed ID: 1618063	1992
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer research\| PubMed ID: 10919641	2000
Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects. Cancer research\| PubMed ID: 10919669	2000
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Oncogene\| PubMed ID: 11704822	2001
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. Oncogene\| PubMed ID: 12527893	2003
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). The Journal of clinical endocrinology and metabolism\| PubMed ID: 12679489	2003
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomas. Annales d'endocrinologie\| PubMed ID: 12707638	2003
Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes. Oncogene\| PubMed ID: 12730683	2003
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. Oncogene\| PubMed ID: 12771945	2003
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. Oncogene\| PubMed ID: 12881713	2003
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. Oncogene\| PubMed ID: 14981541	2004
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene\| PubMed ID: 15184868	2004
Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Strahlentherapie und Onkologie : Organ der Deutschen RÃ¶ntgengesellschaft ... [et al]\| PubMed ID: 15378187	2004
Chimeric G alpha i2/G alpha 13 proteins reveal the structural requirements for the binding and activation of the RGS-like (RGL)-containing Rho guanine nucleotide exchange factors (GEFs) by G... The Journal of biological chemistry\| PubMed ID: 15485891	2004
Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene\| PubMed ID: 15516973	2005
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment. Annals of biomedical engineering\| PubMed ID: 15535057	2004
Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 15734207	2005
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. The Journal of clinical investigation\| PubMed ID: 15761501	2005
Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 15885831	2005
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. The Journal of clinical endocrinology and metabolism\| PubMed ID: 15998773	2005
Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. The Journal of biological chemistry\| PubMed ID: 16123044	2005
Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology\| PubMed ID: 16172572	2005
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science (New York, N.Y.)\| PubMed ID: 16293724	2005
Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16299231	2005
Robo4 signaling in endothelial cells implies attraction guidance mechanisms. The Journal of biological chemistry\| PubMed ID: 16481322	2006
Gene expression changes in a patient presenting nonleukaemic nasal granulocytic sarcoma to acute myelogenous leukaemia using 40 K cDNA microarray. Clinical and laboratory haematology\| PubMed ID: 16898967	2006
Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection. Cancer research\| PubMed ID: 17145847	2006
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer research\| PubMed ID: 17210721	2007
Rac inhibits thrombin-induced Rho activation: evidence of a Pak-dependent GTPase crosstalk. Journal of molecular signaling\| PubMed ID: 17224083	2006
Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniq... Tumori\| PubMed ID: 17455878	2007
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer research\| PubMed ID: 17981789	2007
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. British journal of cancer\| PubMed ID: 17987038	2007
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer research\| PubMed ID: 18089812	2007
Dysregulated RET signaling in thyroid cancer. Endocrinology and metabolism clinics of North America\| PubMed ID: 18502331	2008
Receptor tyrosine kinase inhibitors in thyroid cancer. Best practice & research. Clinical endocrinology & metabolism\| PubMed ID: 19041829	2008
Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19107121	2009
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. Cancer research\| PubMed ID: 19223551	2009
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience. American journal of clinical pathology\| PubMed ID: 19289591	2009
SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. PloS one\| PubMed ID: 19495415	2009
Diffraction imaging of spheres and melanoma cells with a microscope objective. Journal of biophotonics\| PubMed ID: 19593764	2009
Thyroid cancer and inflammation. Molecular and cellular endocrinology\| PubMed ID: 19835928	2010
Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy\| PubMed ID: 19878059	2009
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization. Clinical endocrinology\| PubMed ID: 20039896	2010
Laboratory monitoring of new anticoagulants. American journal of hematology\| PubMed ID: 20131309	2010
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocrine-related cancer\| PubMed ID: 20576801	2010
Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience. American journal of clinical pathology\| PubMed ID: 21571959	2011
SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and FoxO3a. PloS one\| PubMed ID: 21909393	2011
Inhibition of tumor cell migration and metastasis by the proton-sensing GPR4 receptor. Cancer letters\| PubMed ID: 21917373	2011
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. Cancer research\| PubMed ID: 22271686	2012
Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy. Journal of thyroid research\| PubMed ID: 22496986	2011
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Endocrine-related cancer\| PubMed ID: 22919068	2012
Brief report: mesenchymal stromal cell atrophy in coculture increases aggressiveness of transformed cells. Stem cells (Dayton, Ohio)\| PubMed ID: 23404893	2013